PDCD1 and diffuse large B-cell lymphoma: With the exception of r/r primary mediastinal large B-cell lymphoma [8], various subtypes of non-Hodgkin lymphoma (NHL), including diffuse large B-cell lymphoma (DLBCL), have shown to be less sensitive to anti-PD-1 therapy [9,10].